Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the MRI Contrast Media market right now?
The market size for MRI contrast media has experienced robust growth lately. Projections show an increase from $1.56 billion in 2024 to $1.66 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.4%. This notable growth in the historical period is the result of several factors, including the surging demand for early diagnosis, the increasing need for diagnostic precision and improved patient results, heightened public consciousness, the advent of combined imaging methods, and the discovery of new applications for contrast agents.
How fast Is the mri contrast media market expected to grow, and what’s its future value?
Expectations are high for the MRI contrast media market as strong growth is predicted in the coming years. The market is projected to burgeon to a valuation of $2.11 billion by 2029, expanding at a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period can be ascribed to increased instances of cancer, the rise of chronic diseases, escalated investment and activity in research and development, as well as larger healthcare expenditure and the broadening applications of MRI. The forecast period is also likely to witness several significant trends such as collaborative research advancements, technological progressions, product innovation, and the development of contrast agents with heightened safety and efficacy. These product innovations by biotechnological and pharmaceutical companies also promote development in the market.
Get your mri contrast media market report here!
https://www.thebusinessresearchcompany.com/report/mri-contrast-media-global-market-report
What are the leading drivers of growth in the mri contrast media market?
The MRI contrast media market is projected to expand due to a surge in cancer incidences. The cancer rise is multifaceted, shaped by demographic, lifestyle, environmental, genetic, and healthcare factors. Gadolinium-based compounds, utilized as contrast agents during MRI scans, heighten visual clarity by modifying tissue magnetic properties. This helps in identifying, measuring, and characterizing tumors, along with evaluating their encroachment into adjacent tissues. For example, a report by the World Health Organization (WHO), a Switzerland-based intergovernmental organization, in February 2024, stated that the global number of new cancer cases hit 20 million in 2022, causing 9.7 million fatalities. Predictions indicate a substantial increase in cancer cases by 2050, with over 35 million new cases expected, marking a 77% increase from the estimated 20 million cases in 2022. Consequently, the upward trend in cancer incidences is fuelling the growth of the MRI contrast media market.
What are the key segments defining the mri contrast media market?
The mri contrast media market covered in this report is segmented –
1) By Product: Extracellular Contrast Agents, Blood-Pool Agent, Hepatobiliary Agents
2) By Application: Neurological Disorders, Musculoskeletal Disorders, Cardiovascular Disorders, Cancer Detection, Other Applications
3) By End-User: Hospitals, Diagnostic And Imaging Centers, Research Institutes, Other End Users
Subsegments:
1) By Extracellular Contrast Agents: Gadolinium-Based Contrast Agents (GBCA), Non-Gadolinium-Based Contrast Agents
2) By Blood-Pool Agent: Macromolecular Agents, Nanoparticle-Based Agents
3) By Hepatobiliary Agents: Hepatocyte-Specific Agents, Biliary-Specific Agents
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14964&type=smp
Who are the key players steering the development of the mri contrast media market?
Major companies operating in the MRI contrast media market are Bayer AG, GE Healthcare Technologies Inc., Fresenius Kabi AG, Fujifilm Holdings Corporation, JB Chemicals and Pharmaceuticals Ltd., Jiangsu Hengrui Pharmaceutical Co. Ltd., Bracco S.p.A., Miltenyi Biotec B.V. & Co. KG, Lantheus Medical Imaging Inc., Guerbet LLC, Curium Pharma, Spago Nanomedical AB, AMAG Pharmaceuticals Inc., Nanopet Pharma GmbH, Trivitron Healthcare, Beijing Beilu Pharmaceuticals Company Limited, Unijules Life Sciences Ltd., Taejoon Pharm Co. Ltd., Mediso USA LLC, Nano Therapeutics Pvt. Ltd., Livealth Biopharma Pvt Ltd., BioPAL Inc., Vitalquan LLC, Shubhra Biotech Pvt Ltd., Rege Imaging & Cine Films Private Limited, Polarean Inc.
What emerging trends are influencing the growth of the mri contrast media market?
Top corporations in the MRI contrast media market are directing their efforts towards the development and distribution of progressive products, such as macrocyclic gadolinium-based contrast agents (GBCA), in their bid to boost the diagnostic potential and safety of MRI imaging methods. A macrocyclic gadolinium-based contrast agent (GBCA) is essentially a category of contrasts used in medical imaging, predominantly in Magnetic Resonance Imaging (MRI). For illustration, in February 2023, Guerbet, a company based in France that offers MRI contrast media, introduced the Elucirem (gadopiclenol) injection into the market. The characteristic feature of Elucirem (gadopiclenol) injection is its extremely stable macrocyclic gadolinium-based contrast agent (GBCA), boasting the highest relaxivity in its segment for MRI. This novel formulation of gadopiclenol is significant for its capacity to identify and illustrate vascular abnormalities in lesions across various parts of the central nervous system (like the brain, spine and related tissues) and the body, including the head and neck, thorax, abdomen, pelvis and musculoskeletal system.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
Which regions are most influential in expanding the mri contrast media market?
North America was the largest region in the MRI contrast media market in 2024. The regions covered in the MRI contrast media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Media Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/media-global-market-report
Print Media Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/print-media-global-market-report
Contrast Enhanced Ultrasound Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/contrast-enhanced-ultrasound-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
